Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pennex Labs

Executive Summary

Signs consent agreement with FDA on June 26 that allows continued operations. The Verona, Pa.-based OTC health and beauty aids manufacturer was charged in a May FDA complaint with violations of Good Manufacturing Practices rules. The government complaint sought both temporary and permanent injunctions againt the company. Pennex announced June 2 that it was revamping its GMP procedures under a new management team led by ex-Akzo/PBI exec Jack Van Hulst ("The Pink Sheet" June 8, T&G-3).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021138

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel